Amphiregulin

N/A

Report date: 2024/11/29 16:57:24

Base Information

Drug NameAmphiregulin
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulatorsAmphiregulin replacement
TargetsEpidermal growth factor receptor erbB1Amphiregulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A